These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 34457

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Role of the alpha agonist activity of dobutamine in mediating cardiac output: effects of prolonged isoproterenol infusion.
    Hayes JS, Bowling N.
    J Pharmacol Exp Ther; 1987 Jun; 241(3):861-9. PubMed ID: 2885411
    [Abstract] [Full Text] [Related]

  • 24. Cardiovascular effects of YM-16151-1 and its optical isomers: a novel calcium entry blocking and beta 1-adrenoceptor blocking agent.
    Uchida W, Shibasaki K, Asano M, Takenaka T.
    Arch Int Pharmacodyn Ther; 1993 Jun; 321():30-40. PubMed ID: 8100704
    [Abstract] [Full Text] [Related]

  • 25. The comparative hemodynamic effects of propranolol in chronically instrumented puppies and adult dogs.
    Driscoll DJ, Fukushige J, Lewis RM, Hartley CJ, Entman MJ.
    Biol Neonate; 1982 Jun; 41(1-2):8-15. PubMed ID: 7066441
    [Abstract] [Full Text] [Related]

  • 26. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ.
    Pol J Pharmacol; 1998 Jun; 50(3):203-12. PubMed ID: 9861628
    [Abstract] [Full Text] [Related]

  • 27. Adrenoceptor blockade of the circulatory responses to intravenous isoproterenol.
    Richards DA, Prichard BN, Dobbs RJ.
    Clin Pharmacol Ther; 1978 Sep; 24(3):264-73. PubMed ID: 28869
    [No Abstract] [Full Text] [Related]

  • 28. Cardiovascular actions of xamoterol (ICI 118,587) in anaesthetized cats, rats, and guinea pigs.
    Mian MA, Malta E, Raper C.
    J Cardiovasc Pharmacol; 1986 Sep; 8(2):314-23. PubMed ID: 2422470
    [Abstract] [Full Text] [Related]

  • 29. The selectivity of beta-adrenoceptor antagonists on cardiovascular and bronchodilator responses to isoprenaline in the anaesthetized dog.
    Daly MJ, Flook JJ, Levy GP.
    Br J Pharmacol; 1975 Feb; 53(2):173-81. PubMed ID: 238697
    [Abstract] [Full Text] [Related]

  • 30. Hemodynamic characterization of a new beta-receptor blocker: mepindolol at rest, during ergometer exercise and in the isoproterenol study in comparison with practolol and pindolol.
    Boneli J.
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):325-31. PubMed ID: 19363
    [No Abstract] [Full Text] [Related]

  • 31. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE, Cavero I, Manoury P, Lefevre-Borg F, Langer SZ.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [Abstract] [Full Text] [Related]

  • 32. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT, Levy GP.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [Abstract] [Full Text] [Related]

  • 33. Some cardiovascular effects of timolol a new beta-adrenergic blocking agent.
    Scriabine A, Torchiana ML, Stavorski JM, Ludden CT, Minsker DH, Stone CA.
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):76-93. PubMed ID: 4148410
    [No Abstract] [Full Text] [Related]

  • 34. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL.
    J Cardiovasc Pharmacol; 1983 Sep; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [Abstract] [Full Text] [Related]

  • 35. Effects of beta-adrenoceptor blockade on prostacyclin mediated renin release in sheep.
    Mason RT, Coghlan JP, Denton DA, Fei DW, Whitworth JA, Scoggins BA.
    Clin Exp Pharmacol Physiol; 1984 Sep; 11(6):571-7. PubMed ID: 6152609
    [Abstract] [Full Text] [Related]

  • 36. Effect of vasodilatory beta-adrenoceptor blockers on cardiovascular haemodynamics in anaesthetized rats.
    Takahashi H, Masaki H, Komiyama Y, Masuda M, Nishimura M.
    Clin Exp Pharmacol Physiol; 2002 Mar; 29(3):198-203. PubMed ID: 11906483
    [Abstract] [Full Text] [Related]

  • 37. Effects of tertatolol, a beta-adrenoceptor antagonist with agonist affinity at 5-HT1A receptors, in an animal model of migraine: comparison with propranolol and pindolol.
    Saxena PR, Heiligers JP, Villalón CM, Ferrari MD.
    Eur J Pharmacol; 1992 Sep 10; 220(1):79-86. PubMed ID: 1358648
    [Abstract] [Full Text] [Related]

  • 38. The acute effects of a non-selective beta-adrenergic blocking agent in hypertensive pregnant rats.
    Karlsson K, Lundgren Y, Ljungblad U.
    Acta Obstet Gynecol Scand Suppl; 1984 Sep 10; 118():81-4. PubMed ID: 6145287
    [Abstract] [Full Text] [Related]

  • 39. Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.
    O'Connor PC, Finch MJ, Harron DW, Meredith PA, McDevitt DG, Shanks RG.
    Br J Clin Pharmacol; 1985 Dec 10; 20(6):659-67. PubMed ID: 2868744
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of the early circulatory effects of triiodothyronine in rats by propranolol.
    Kapitola J, Vilimovská D.
    Physiol Bohemoslov; 1981 Dec 10; 30(4):347-51. PubMed ID: 6458055
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.